Get started
Author

Geneviève Laflamme

Observed names: G Laflamme, G. Laflamme, GENEVIèVE LAFLAMME, Genevieve LaFlamme, Genevieve Laflamme, Geneviève Laflamme, Laflamme, Geneviève
Observed institutions: Héma-Québec, University of British Columbia, Inserm, St. Paul's Hospital, Centre Hospitalier Universitaire de Nantes, Centre hospitalier universitaire de Québec, Institut de Transplantation Urologie en Nephrologie, Centre hospitalier de l'Université Laval, Gilead Sciences (United States), Université Laval, Centre de recherche du CHU de Québec-Université Laval, CHU de Québec-Université Laval, Centre de recherche CERVO, Université du Québec à Trois-Rivières
ORCID: 0009-0003-0079-2335
Observed ORCID: 0009-0003-0079-2335
OpenAlex ID: A5069143260
Design and Profiling of GS-9148, a Novel Nucleotide Analog Active against Nucleoside-Resistant Variants of Human Immunodeficiency Virus Type 1, and Its Orally Bioavailable Phosphonoamidate Prodrug, GS-9131
2007 · Tomas Cihlar, Adrian S. Ray, et al. · Antimicrobial Agents and Chemotherapy · 93
Molecular Assessment of the Potential for Renal Drug Interactions between Tenofovir and HIV Protease Inhibitors
2007 · Tomas Cihlar, Adrian S Ray, et al. · Antiviral Therapy · 91
Common Respiratory Viruses in Lower Airways of Patients with Acute Hypersensitivity Pneumonitis
1999 · AZZEDDINE DAKHAMA, RICHARD G. HEGELE, et al. · American Journal of Respiratory and Critical Care Medicine · 81
Selective blockade of CD28 and not CTLA-4 with a single-chain Fv–α1-antitrypsin fusion antibody
2003 · Bernard Vanhove, Geneviève Laflamme, et al. · Blood · 72
Discovery of GS-9131: Design, synthesis and optimization of amidate prodrugs of the novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor GS-9148
2010 · Richard L. Mackman, Adrian S. Ray, et al. · Bioorganic & Medicinal Chemistry · 60
Novel Nucleotide Human Immunodeficiency Virus Reverse Transcriptase Inhibitor GS-9148 with a Low Nephrotoxic Potential: Characterization of Renal Transport and Accumulation
2008 · Tomas Cihlar, Genevieve LaFlamme, et al. · Antimicrobial Agents and Chemotherapy · 57
Design, synthesis, and anti-HIV activity of 4′-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors
2008 · Constantine G. Boojamra, Jay P. Parrish, et al. · Bioorganic & Medicinal Chemistry · 56
5′ untranslated sequences modulate rapid mRNA degradation mediated by 3′ AU-rich element in v-/c-fosrecombinants
1992 · Nathalie Roy, Geneviève Laflamme, et al. · Nucleic Acids Research · 42
Synthesis of 3′-O-phosphonomethyl nucleosides with an adenine base moiety
2007 · Dolores Viña, Tongfei Wu, et al. · Tetrahedron · 35
Synthesis of Ester Prodrugs of 9-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as Anti-Poxvirus Agents
2010 · Marcela Krečmerová, Antonín Holý, et al. · Journal of Medicinal Chemistry · 32
Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugs
2007 · Richard L. Mackman, Lijun Zhang, et al. · Bioorganic & Medicinal Chemistry · 32
Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses
2002 · Fabienne Haspot, Florence Villemain, et al. · Blood · 29
Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression
2007 · M Robinson, Y Ge, et al. · Cancer Gene Therapy · 19
Synthesis And Anti-Hiv Activity Of Cyclic Pyrimidine Phosphonomethoxy Nucleosides And Their Prodrugs: A Comparison Of Phosphonates And Corresponding Nucleosides
2007 · Richard L. Mackman, Lijun Zhang, et al. · Nucleosides Nucleotides & Nucleic Acids · 18
Validated Reference Panel from Renewable Source of Genomic DNA Available for Standardization of Blood Group Genotyping
2019 · Evgeniya Volkova, Emilia Sippert, et al. · Journal of Molecular Diagnostics · 13
PDF
Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited
2024 · Gabriel André Leiva‐Torres, Maude Cigna, et al. · Transfusion · 10
Adrenal insufficiency among children treated with hormonal therapy for infantile spasms
2022 · Gabrielle Doré‐Brabant, Geneviève Laflamme, et al. · Epilepsia · 7
Synthesis of Ester Prodrugs of 9-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as Anti-Poxvirus Agents
2010 · Marcela Krecmerova, Antonin Holy, et al. · Antiviral Research · 2
Synthesis and antiviral activity of 4'-modified carbocyclic nucleoside phosphonates (CNPs)
2008 · R. L. Mackman, C. G. Boojamra, et al. · 2
Pilot study on cannabis-induced alterations in platelet function: implications for transfusion medicine
2026 · Geneviève Laflamme, Hind Hamzeh-Cognasse, et al. · Platelets · 1
Eosinophil Activation Status and Corticosteroid Responsiveness in Severe Asthma
2000 · M. Bossé, M. Audette, et al. · International Archives of Allergy and Immunology · 1
PB2584 Cannabis-Induced Alterations in Platelet Function: Implications for Transfusion Medicine
2026 · Geneviève Laflamme, Hind Hamzeh-Cognasse, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
Management of Status Epilepticus in Children before and after Implementation of a Treatment Algorithm
2026 · Anne-Sophie Bard, Noémie Savard, et al. · The Canadian Journal of Hospital Pharmacy
Healthcare professionals’ practices and barriers in assessing and promoting physical activity in primary care: a descriptive study
2025 · Laflamme, Geneviève, Trudeau, François, et al. · Figshare
Additional file 1 of Healthcare professionals’ practices and barriers in assessing and promoting physical activity in primary care: a descriptive study
2025 · Laflamme, Geneviève, Trudeau, François, et al. · Figshare
Works count: 31
Citation count: 753
H-index: 14
I10-index: 16
Year
Topic
Type